Privatdozent of Anesthesiology, Institute of Anesthesiology, University Hospital Zurich, Raemistrasse 100, CH-8091 Zurich, Switzerland.
Best Pract Res Clin Anaesthesiol. 2010 Mar;24(1):15-25. doi: 10.1016/j.bpa.2009.09.010.
Abnormal coagulation parameters can be found in 25% of trauma patients with major injuries. Furthermore, trauma patients presenting with coagulopathy on admission have worse clinical outcome. Tissue trauma and systemic hypoperfusion appear to be the primary factors responsible for the development of acute traumatic coagulopathy immediately after injury. As a result of overt activation of the protein C pathway, the acute traumatic coagulopathy is characterised by coagulopathy in conjunction with hyperfibrinolysis. This coagulopathy can then be exacerbated by subsequent physiologic and physical derangements such as consumption of coagulation factors, haemodilution, hypothermia, acidemia and inflammation, all factors being associated with ongoing haemorrhage and inadequate resuscitation or transfusion therapies. Knowledge of the different mechanisms involved in the pathogenesis of acute traumatic coagulopathy is essential for successful management of bleeding trauma patients. Therefore, early evidence suggests that treatment directed at aggressive and targeted haemostatic resuscitation can lead to reductions in mortality of severely injured patients.
25%的严重创伤患者会出现凝血参数异常。此外,入院时即出现凝血功能障碍的创伤患者临床预后更差。组织创伤和全身低灌注似乎是损伤后即刻发生急性创伤性凝血病的主要因素。由于蛋白 C 途径的明显激活,急性创伤性凝血病的特征是凝血功能障碍伴纤维蛋白溶解亢进。随后的生理和物理紊乱,如凝血因子消耗、血液稀释、低体温、酸中毒和炎症,可使这种凝血病进一步恶化,所有这些因素都与持续出血以及不充分的复苏或输血治疗相关。了解急性创伤性凝血病发病机制中涉及的不同机制对于成功治疗出血性创伤患者至关重要。因此,早期证据表明,针对积极和靶向止血复苏的治疗可能会降低严重受伤患者的死亡率。